686 related articles for article (PubMed ID: 17182565)
1. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
[TBL] [Abstract][Full Text] [Related]
2. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
Soper DM; Kasprowicz DJ; Ziegler SF
Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
4. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
[TBL] [Abstract][Full Text] [Related]
5. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.
Yu A; Zhu L; Altman NH; Malek TR
Immunity; 2009 Feb; 30(2):204-17. PubMed ID: 19185518
[TBL] [Abstract][Full Text] [Related]
6. Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients.
Zheng CF; Jones GJ; Shi M; Wiseman JC; Marr KJ; Berenger BM; Huston SM; Gill MJ; Krensky AM; Kubes P; Mody CH
J Immunol; 2008 Jun; 180(11):7221-9. PubMed ID: 18490721
[TBL] [Abstract][Full Text] [Related]
7. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
8. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
Yu A; Malek TR
J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
[TBL] [Abstract][Full Text] [Related]
9. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
10. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.
Vang KB; Yang J; Mahmud SA; Burchill MA; Vegoe AL; Farrar MA
J Immunol; 2008 Sep; 181(5):3285-90. PubMed ID: 18714000
[TBL] [Abstract][Full Text] [Related]
11. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
[TBL] [Abstract][Full Text] [Related]
12. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
Carrier Y; Yuan J; Kuchroo VK; Weiner HL
J Immunol; 2007 Jan; 178(1):172-8. PubMed ID: 17182552
[TBL] [Abstract][Full Text] [Related]
13. CXCL4 promoted the production of CD4
Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
[No Abstract] [Full Text] [Related]
14. In vivo maintenance of human regulatory T cells during CD25 blockade.
Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
[TBL] [Abstract][Full Text] [Related]
15. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the
Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H
J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311
[TBL] [Abstract][Full Text] [Related]
16. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
17. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
18. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of Wuwei Xiaodu Drink against chronic osteomyelitis through Foxp3
Huang K; Ren HY; Lin BY; Liu YY; Guo QF
Chin J Nat Med; 2022 Mar; 20(3):185-193. PubMed ID: 35369962
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.
Ruiz-Medina BE; Ross JA; Kirken RA
J Biol Chem; 2015 Aug; 290(34):20972-20983. PubMed ID: 26152718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
